<?xml version='1.0' encoding='utf-8'?>
<document id="31130788"><sentence text="Antimicrobial Agents-induced Hypokalemia: A Possible Causality Association." /><sentence text="Drugs including some of the antimicrobial agents (AMAs) can cause mild to severe intensity of hypokalemia, which leads to cardiac, muscular, renal, gastrointestinal, and metabolic manifestations" /><sentence text="" /><sentence text="To explore the possible association of AMAs use and the development of hypokalemia as an adverse drug reaction (ADR)" /><sentence text="" /><sentence text="Retrospective analysis of spontaneously individual case safety reports (ICSRs) received during January 2015 to September 2017 for any reduction in serum potassium levels following the use of AMAs"><entity charOffset="153-162" id="DDI-PubMed.31130788.s6.e0" text="potassium" /></sentence><sentence text=" Such ICSRs were further analyzed for age, gender, seriousness and severity of hypokalemia, outcome, concomitant drugs, management of hypokalemia, and causality assessment using WHO-UMC causality assessment scale" /><sentence text="" /><sentence text="Out of total 2,880 spontaneous ICSR, 53 had report title of hypokalemia" /><sentence text=" In almost half of these (27) ICSRs, AMAs were suspected to induced hypokalemia" /><sentence text=" Ceftriaxone (24"><entity charOffset="1-12" id="DDI-PubMed.31130788.s11.e0" text="Ceftriaxone" /></sentence><sentence text="5%) and azithromycin (10"><entity charOffset="8-20" id="DDI-PubMed.31130788.s12.e0" text="azithromycin" /></sentence><sentence text="5%) were most suspected AMAs" /><sentence text=" Females (74" /><sentence text="19%) aged between 21 years and 40 years experienced more AMA induced hypokalemia" /><sentence text=" The mild, moderate, and severe hypokalemia was present in 53" /><sentence text="8%, 40" /><sentence text="7%, and 7" /><sentence text="4% of ICSRs, respectively" /><sentence text=" Drug-drug interaction of AMA with either furosemide, hydrocortisone and/or deriphyllin was present in six ICSRs"><entity charOffset="42-52" id="DDI-PubMed.31130788.s20.e0" text="furosemide" /><entity charOffset="54-68" id="DDI-PubMed.31130788.s20.e1" text="hydrocortisone" /><entity charOffset="76-87" id="DDI-PubMed.31130788.s20.e2" text="deriphyllin" /><pair ddi="false" e1="DDI-PubMed.31130788.s20.e0" e2="DDI-PubMed.31130788.s20.e0" /><pair ddi="false" e1="DDI-PubMed.31130788.s20.e0" e2="DDI-PubMed.31130788.s20.e1" /><pair ddi="false" e1="DDI-PubMed.31130788.s20.e0" e2="DDI-PubMed.31130788.s20.e2" /><pair ddi="false" e1="DDI-PubMed.31130788.s20.e1" e2="DDI-PubMed.31130788.s20.e1" /><pair ddi="false" e1="DDI-PubMed.31130788.s20.e1" e2="DDI-PubMed.31130788.s20.e2" /></sentence><sentence text=" Causal association of all the ICSRs with AMA induced hypokalemia was possible" /><sentence text="" /><sentence text="Antimicrobial agents (especially ceftriaxone and azithromycin)-induced hypokalemia alert needs to be investigated"><entity charOffset="33-44" id="DDI-PubMed.31130788.s23.e0" text="ceftriaxone" /></sentence><sentence text=" Further, healthcare professionals are advocated to take caution by monitoring serum potassium levels routinely for such patients"><entity charOffset="85-94" id="DDI-PubMed.31130788.s24.e0" text="potassium" /></sentence><sentence text="" /><sentence text="Rehan HS, Hotha P, Antimicrobial Agentsinduced Hypokalemia: A Possible Causality Association" /><sentence text=" Indian J Crit Care Med 2019;23(4):175-177" /><sentence text="" /></document>